Clinical Trials Browser

Phase EARLY_PHASE1 × Neurilemmoma × HDAC-42 × Clear all

NCT02282917 2025-12-05

Exploratory Evaluation of AR-42 Histone Deacetylase Inhibitor in the Treatment of Vestibular Schwannoma and Meningioma

Phase EARLY_PHASE1 Terminated

7 enrolled 19 charts

Meningioma, Neurilemmoma, Neuroma, Acoustic, Neurofibromatosis 2